Cromwell Holdings »

Regeneron Pharmaceuticals shares owned by Cromwell Holdings

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Cromwell Holdings from 13F filings

Historical chart of Cromwell Holdings investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Cromwell Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Cromwell Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $245k 233 1051.24
2024-06-30 $245k 233 1051.03

More positions owned by Cromwell Holdings

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
NVIDIA Corp Common Stock (NVDA)
ishares Trust MSCI EMG MKT ETF Etf (EEM)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc CL A Class A Shares (META)
Alphabet Inc. CAP STK CL A Class A Shares (GOOGL)
Berkshire Hathaway Inc. CL B Common Stock (BRK.B)
Alphabet Inc. CAP STK CL C Common Stock (GOOG)
Eli Lilly & Co Common Stock (LLY)
Broadcom Common Stock (AVGO)
Tesla Common Stock (TSLA)
JPMorgan Chase & Co Common Stock (JPM)
UnitedHealth Group Common Stock (UNH)
Exxon Mobil Corp Common Stock (XOM)

View all positions for Cromwell Holdings

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
T. Rowe Price Associates
Loomis, Sayles and
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals